Home › Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi
 

Keywords :   


Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi

2014-08-16 09:15:14| Biotech - Topix.net

An arbitration panel ruled Friday that the Foster City-based drug maker's hepatitis C blockbuster Sovaldi did not infringe a 2004 research deal that rival Roche had with Pharmasset Inc. Gilead , led by Chairman and CEO John Martin , bought Pharmasset in 2012 for $11 billion, landing the drug that would become Sovaldi.

Tags: back drug victory wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.11Amino updates Android STB portfolio with Amigo 7Y launch
07.11Sainsbury's and M&S warn Budget may push up prices
07.11VIZIO reports Q3 2024 financial results
07.11Farm Progress America, Nov. 7, 2024
07.11NanoTech Materials Named to TIMEs List of the Best Inventions of 2024
07.11Farm Progress America, Nov. 7, 2024
07.11ORF and ORS extend contract with SES at 19.2° East
07.11Victory+ to monetize over 60 new FAST channels with Amagi
More »